RESUMO
AIM AND OBJECTIVE: The importance of Chromeno[4,3-b]pyridines in bioactive compounds, highlighted the ongoing research on developing novel methods for the construction of this heterocyclic scaffold. Regarding the advantageous features of multi-component reactions in organic synthesis, we will try to synthesize pyridocoumarins through this method. MATERIALS AND METHODS: Chromeno[4,3-b]pyridines were conveniently prepared from a threecomponent condensation reaction between 4-hydroxy coumarin, ammonia and ethyl 2,4-dioxo-4- arylbutanoates in refluxing n-propanol. The synthesized compounds were characterized by NMR, IR and Mass spectroscopy. RESULTS: The reaction proceeded through an in situ formed 4-amino coumarin, affording eight new target compounds in good yields. CONCLUSION: This method introduce a novel approach to ethyl 4-aryl-5-oxo-5H-chromeno[4,3- b]pyridine-2-carboxylate derivatives and allow organic chemists to prepare 4-aminocoumarin in reaction medium.
Assuntos
Benzopiranos/síntese química , Piridinas/síntese química , Aminocumarinas/síntese química , Amônia/química , Ácido Butírico/química , Estrutura Molecular , Solventes/química , TemperaturaRESUMO
A novel series of dihydropyrano[3,2-c]quinoline derivatives 6a-q were synthesized and evaluated for their in vitro α-glucosidase inhibitory activities. All newly synthesized compounds displayed potent α-glucosidase inhibitory activity in the range of 10.3⯱â¯0.3⯵M-172.5⯱â¯0.8⯵M against the yeast α-glucosidase enzyme when compared to the standard drug acarbose (IC50â¯=â¯750.0⯱â¯1.5⯵M). Among these compounds, compounds 6e and 6d displayed the most potent α-glucosidase inhibitory activity (IC50â¯=â¯10.3⯱â¯0.3 and 15.7⯱â¯0.5⯵M, respectively). The kinetic analysis of the most potent compounds 6e and 6d revealed that compound 6e inhibited α-glucosidase in an uncompetitive manner (Kiâ¯=â¯11⯵M) while compound 6d was a non-competitive inhibitor (Kiâ¯=â¯28⯵M) of the enzyme. Then, the cytotoxicity of the most potent compounds (i.e., compounds 6a, 6d, 6e, 6â¯g, 6j, and 6l) were evaluated for toxicity using the breast cancer cell lines MDA-MB231, MCF-7, and T-47D by using a MTT assay, and no toxicity was observed.